
Brenda Libby Coleman
Examiner (ID: 14798)
| Most Active Art Unit | 1624 |
| Art Unit(s) | 1624, 2611, 1611, 1202 |
| Total Applications | 3171 |
| Issued Applications | 1983 |
| Pending Applications | 480 |
| Abandoned Applications | 745 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 10587600
[patent_doc_number] => 09309200
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-12
[patent_title] => 'Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy'
[patent_app_type] => utility
[patent_app_number] => 13/468682
[patent_app_country] => US
[patent_app_date] => 2012-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38099
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13468682
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/468682 | Benzazepine derivatives, pharmaceutical compositions containing them, and their use in therapy | May 9, 2012 | Issued |
Array
(
[id] => 11191491
[patent_doc_number] => 09422292
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-23
[patent_title] => 'Bromodomain inhibitors and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/114983
[patent_app_country] => US
[patent_app_date] => 2012-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64396
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 5
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14114983
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/114983 | Bromodomain inhibitors and uses thereof | May 3, 2012 | Issued |
Array
(
[id] => 9307153
[patent_doc_number] => 20140045827
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-02-13
[patent_title] => 'NOVEL ANTIFUNGAL 5,6-DIHYDRO-4H-PYRROLO[1,2-a][1,4]BENZO-DIAZEPINES AND 6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINES SUBSTITUTED WITH HETEROCYCLIC DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 14/113356
[patent_app_country] => US
[patent_app_date] => 2012-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35688
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14113356
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/113356 | Antifungal 5,6-dihydro-4H-pyrrolo[1,2-a][1,4]benzo-diazepines and 6H-pyrrolo[1,2-a][1,4]benzodiazepines substituted with heterocyclic derivatives | May 2, 2012 | Issued |
Array
(
[id] => 8496484
[patent_doc_number] => 20120295892
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-11-22
[patent_title] => 'GABAERGIC RECEPTOR SUBTYPE SELECTIVE LIGANDS AND THEIR USES'
[patent_app_type] => utility
[patent_app_number] => 13/458168
[patent_app_country] => US
[patent_app_date] => 2012-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 25170
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13458168
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/458168 | Gabaergic receptor subtype selective ligands and their uses | Apr 26, 2012 | Issued |
Array
(
[id] => 8429630
[patent_doc_number] => 20120251497
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'INHIBITORS OF HEPATITIS C VIRUS'
[patent_app_type] => utility
[patent_app_number] => 13/456181
[patent_app_country] => US
[patent_app_date] => 2012-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 75250
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13456181
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/456181 | Inhibitors of hepatitis C virus | Apr 24, 2012 | Issued |
Array
(
[id] => 8612872
[patent_doc_number] => 20130018184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-01-17
[patent_title] => 'METHODS OF PREPARING POLYMORPHIC FORM A OF BAZEDOXIFENE ACETATE'
[patent_app_type] => utility
[patent_app_number] => 13/453574
[patent_app_country] => US
[patent_app_date] => 2012-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 5982
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13453574
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/453574 | Methods of preparing polymorphic form A of bazedoxifene acetate | Apr 22, 2012 | Issued |
Array
(
[id] => 9686551
[patent_doc_number] => 20140243317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-08-28
[patent_title] => 'DIBENZOTHIAZEPINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS'
[patent_app_type] => utility
[patent_app_number] => 14/112499
[patent_app_country] => US
[patent_app_date] => 2012-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 14370
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14112499
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/112499 | Dibenzothiazepine derivatives and their use in the treatment of CNS disorders | Apr 15, 2012 | Issued |
Array
(
[id] => 9312038
[patent_doc_number] => 08653257
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-02-18
[patent_title] => 'Dibenzothiazepine derivatives and uses thereof—424'
[patent_app_type] => utility
[patent_app_number] => 13/445347
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11700
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445347
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/445347 | Dibenzothiazepine derivatives and uses thereof—424 | Apr 11, 2012 | Issued |
Array
(
[id] => 9355364
[patent_doc_number] => 08673898
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-03-18
[patent_title] => 'Aminodiazepines as toll-like receptor modulators'
[patent_app_type] => utility
[patent_app_number] => 13/445749
[patent_app_country] => US
[patent_app_date] => 2012-04-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14834
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13445749
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/445749 | Aminodiazepines as toll-like receptor modulators | Apr 11, 2012 | Issued |
Array
(
[id] => 9363908
[patent_doc_number] => 20140073781
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-13
[patent_title] => 'PROCESS FOR OBTAINING A CHARGE OF HEXANITROHEXAAZAISOWURTZITANE CRYSTALS HAVING A ROUNDED MORPHOLOGY; CHARGE AND CORRESPONDING ENERGETIC MATERIAL'
[patent_app_type] => utility
[patent_app_number] => 14/110621
[patent_app_country] => US
[patent_app_date] => 2012-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5531
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14110621
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/110621 | Process for obtaining a charge of hexanitrohexaazaisowurtzitane crystals having a rounded morphology; charge and corresponding energetic material | Apr 4, 2012 | Issued |
Array
(
[id] => 9339837
[patent_doc_number] => 20140066619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-03-06
[patent_title] => 'PROCESS FOR THE PREPARATION OF 1 - (2-METHYL-4- (2,3,4,5-TETRAHYDRO-1-BENZAZEPIN-1-YLCARBONYL) BENZYLCARBAMOYL) - L - PROLINE - N, N-DIMETHYLAMIDE'
[patent_app_type] => utility
[patent_app_number] => 14/008647
[patent_app_country] => US
[patent_app_date] => 2012-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 3824
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14008647
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/008647 | Process for the preparation of 1-(2-methyl-4-(2,3,4,5-tetrahydro-1-benzazepin-1-ylcarbonyl) benzylcarbamoyl)-L-proline-N, N-dimethylamide | Mar 29, 2012 | Issued |
Array
(
[id] => 8431161
[patent_doc_number] => 20120253035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => '1,4-OXAZEPINES AS BACE1 AND/OR BACE2 INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/432003
[patent_app_country] => US
[patent_app_date] => 2012-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37743
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13432003
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/432003 | 1,4-Oxazepines as BACE1 and/or BACE2 inhibitors | Mar 27, 2012 | Issued |
Array
(
[id] => 8956160
[patent_doc_number] => 08501935
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-08-06
[patent_title] => 'Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto'
[patent_app_type] => utility
[patent_app_number] => 13/427379
[patent_app_country] => US
[patent_app_date] => 2012-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10836
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13427379
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/427379 | Processes for the preparation of 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine and intermediates related thereto | Mar 21, 2012 | Issued |
Array
(
[id] => 8290598
[patent_doc_number] => 20120178926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-07-12
[patent_title] => 'METHODS FOR PREPARING PYRIMIDINE DERIVATIVES USEFUL AS PROTEIN KINASE INHIBITORS'
[patent_app_type] => utility
[patent_app_number] => 13/424736
[patent_app_country] => US
[patent_app_date] => 2012-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28403
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13424736
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/424736 | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors | Mar 19, 2012 | Issued |
Array
(
[id] => 8417646
[patent_doc_number] => 20120245144
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-09-27
[patent_title] => 'BENZOXAZEPIN COMPOUNDS SELECTIVE FOR PI3K P110 DELTA AND METHODS OF USE'
[patent_app_type] => utility
[patent_app_number] => 13/424500
[patent_app_country] => US
[patent_app_date] => 2012-03-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 129945
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13424500
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/424500 | Benzoxazepin compounds selective for PI3K P110 delta and methods of use | Mar 19, 2012 | Issued |
Array
(
[id] => 9205997
[patent_doc_number] => 20140005174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-01-02
[patent_title] => 'INDOLE DERIVATIVES USEFUL AS CCR2 ANTAGONISTS'
[patent_app_type] => utility
[patent_app_number] => 14/004464
[patent_app_country] => US
[patent_app_date] => 2012-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14474
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14004464
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/004464 | INDOLE DERIVATIVES USEFUL AS CCR2 ANTAGONISTS | Mar 13, 2012 | Abandoned |
Array
(
[id] => 8653083
[patent_doc_number] => 08372832
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-02-12
[patent_title] => '1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use'
[patent_app_type] => utility
[patent_app_number] => 13/420071
[patent_app_country] => US
[patent_app_date] => 2012-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11230
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13420071
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/420071 | 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl compounds and their medical use | Mar 13, 2012 | Issued |
Array
(
[id] => 8431162
[patent_doc_number] => 20120253037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => 'METHODS AND COMPOSITIONS FOR PREPARING NORIBOGAINE FROM VOACANGINE'
[patent_app_type] => utility
[patent_app_number] => 13/420479
[patent_app_country] => US
[patent_app_date] => 2012-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3733
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13420479
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/420479 | Methods and compositions for preparing noribogaine from voacangine | Mar 13, 2012 | Issued |
Array
(
[id] => 8430908
[patent_doc_number] => 20120252784
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-10-04
[patent_title] => '2,3,4-BENZOTHIADIAZEPINE-2,2-DIOXIDE DERIVATIVES'
[patent_app_type] => utility
[patent_app_number] => 13/418869
[patent_app_country] => US
[patent_app_date] => 2012-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 15750
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13418869
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/418869 | 2,3,4-BENZOTHIADIAZEPINE-2,2-DIOXIDE DERIVATIVES | Mar 12, 2012 | Abandoned |
Array
(
[id] => 9524153
[patent_doc_number] => 08748418
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2014-06-10
[patent_title] => '1,4-oxazepines as BACE1 and/or BACE2 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 13/415873
[patent_app_country] => US
[patent_app_date] => 2012-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34003
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13415873
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/415873 | 1,4-oxazepines as BACE1 and/or BACE2 inhibitors | Mar 8, 2012 | Issued |